LGND - Ligand Pharmaceuticals Q4 Earnings Preview

February, 05 2020 05:35 PM Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals (NASDAQ:LGND) is scheduled to announce Q4 earnings results on Thursday, February 6th, after market close.
The consensus EPS Estimate is $0.12 (-92.9% Y/Y) and the consensus Revenue Estimate is $25.3M (-57.5% Y/Y).
Over the last 2 years, LGND has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 0 upward revision and 3 downward. Revenue estimates have seen 0 upward revisions and 5 downward.
More news on: Ligand Pharmaceuticals Incorporated, Earnings news and commentary, , Healthcare stocks news,

Company Name:	Ligand Pharmaceuticals Incorporated
Stock Symbol:	LGND
Market:	NASDAQ
Website:	ligand.com